Literature DB >> 21714983

Transformation kinetics of biochemically active compounds in low-pressure UV photolysis and UV/H(2)O(2) advanced oxidation processes.

Carolina Baeza1, Detlef R U Knappe.   

Abstract

Factors controlling photolysis and UV/H2O2 photooxidation rates of the biochemically active compounds (BACs) sulfamethoxazole, sulfamethazine, sulfadiazine, trimethoprim, bisphenol A, and diclofenac were determined. Experiments were conducted with a quasi-collimated beam apparatus equipped with low-pressure UV lamps. The effects of pH, H2O2 concentration, and background water matrix (ultrapure water, lake water, wastewater treatment plant effluent) on BAC transformation rates were evaluated. For the sulfa drugs, solution pH affected direct photolysis rates but had little effect on the hydroxyl radical oxidation rate. For sulfamethoxazole, the neutral form photolyzed more easily than the anionic form while the reverse was the case for sulfamethazine and sulfadiazine. For trimethoprim, the hydroxyl radical oxidation rate was higher for the cationic form (pH 3.6) than for the neutral form (pH 7.85). Quantum yields and second order rate constants describing the reaction between the hydroxyl radical and BACs were determined and used together with background water quality data to predict fluence-based BAC transformation rate constants (k'). For both the lake water and wastewater treatment plant effluent matrices, predicted k' values were generally in good agreement with experimentally determined k' values. At typical UV/H2O2 treatment conditions (fluence=540 mJ cm(-2), H2O2 dose=6 mg L(-1)), BAC transformation percentages in North Carolina lake water ranged from 43% for trimethoprim to 98% for diclofenac. In wastewater treatment plant effluent, BAC transformation percentages were lower (31-97%) at the same treatment conditions because the hydroxyl radical scavenging rate was higher.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21714983     DOI: 10.1016/j.watres.2011.05.039

Source DB:  PubMed          Journal:  Water Res        ISSN: 0043-1354            Impact factor:   11.236


  6 in total

1.  Application of surrogates, indicators, and high-resolution mass spectrometry to evaluate the efficacy of UV processes for attenuation of emerging contaminants in water.

Authors:  Sylvain Merel; Tarun Anumol; Minkyu Park; Shane A Snyder
Journal:  J Hazard Mater       Date:  2014-09-16       Impact factor: 10.588

Review 2.  Analytical tools employed to determine pharmaceutical compounds in wastewaters after application of advanced oxidation processes.

Authors:  Cristina Afonso-Olivares; Sarah Montesdeoca-Esponda; Zoraida Sosa-Ferrera; José Juan Santana-Rodríguez
Journal:  Environ Sci Pollut Res Int       Date:  2016-08-04       Impact factor: 4.223

3.  Oxidative removal of recalcitrant organics in shale gas flowback fluid by the microwave-activated persulfate process.

Authors:  Weiming Chen; Ziyin Luo; Chuanwei Wu; Peng Wen; Qibin Li
Journal:  Environ Sci Pollut Res Int       Date:  2018-11-09       Impact factor: 4.223

4.  Aqueous multivariate phototransformation kinetics of dissociated tetracycline: implications for the photochemical fate in surface waters.

Authors:  Linke Ge; Qianqian Dong; Crispin Halsall; Chang-Er L Chen; Jun Li; Degao Wang; Peng Zhang; Ziwei Yao
Journal:  Environ Sci Pollut Res Int       Date:  2018-03-25       Impact factor: 4.223

5.  Degradation of trimethoprim by sulfate radical-based advanced oxidation processes: kinetics, mechanisms, and effects of natural water matrices.

Authors:  Yiting Luo; Rongkui Su; Haisong Yao; Aoshan Zhang; Siyuan Xiang; Lei Huang
Journal:  Environ Sci Pollut Res Int       Date:  2021-07-01       Impact factor: 5.190

6.  Indirect Photodegradation of Sulfamethoxazole and Trimethoprim by Hydroxyl Radicals in Aquatic Environment: Mechanisms, Transformation Products and Eco-Toxicity Evaluation.

Authors:  Jiaoxue Yang; Guochun Lv; Chenxi Zhang; Zehua Wang; Xiaomin Sun
Journal:  Int J Mol Sci       Date:  2020-08-30       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.